We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 146

Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record


AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 12 2010

The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply


Pfizer v Ranbaxy; 55.2 proceeding; October 5, 2007 - atorvastatin
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 25 2007

The trial judge granted prohibition in respect of one patent claiming a novel crystalline form of atorvastatin (the "crystalline form patent") and denied prohibition in respect of another patent claiming a novel process for making atorvastatin (the "process patent"


Lilly v Novopharm; motion to dismiss appeal for mootness; November 6, 2007 - olanzapine
  • Gowling Lafleur Henderson LLP
  • Canada
  • November 16 2007

The Federal Court of Appeal heard the respondent generic company's motion to dismiss the appeal on the basis of mootness


Lundbeck v. Ratiopharm and Cobalt
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review


Pfizer v. Ranbaxy; appeal of motion to dismiss 55.2 proceeding, S. 6(5); June 18, 2007 Atorvastatin
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 13 2007

The generic company brought a motion to dismiss the proceeding as an abuse of process


Pfizer v. Apotex; 55.2 proceeding; June 15, 2007 quinapril
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 13 2007

The Court dismissed an application for prohibition


Ranbaxy v Pfizer; appeal of interlocutory motion in 55.2
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 13 2007

At the trial division, the innovator succeeded in a motion to amend its Notice of Application for a second time, as its initial amendments had been based on misleading information from the generic company


Recent cases
  • Gowling Lafleur Henderson LLP
  • Canada
  • June 21 2007

The Court of Appeal upheld the decision that the patent was valid and infringed


Apotex v. AB Hassle; appeal motion to dismiss impeachment proceeding; June 27, 2007; omeprazole
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 13 2007

The two companies litigated this patent in proceedings under the PMNOC Regulations